Roland Wandeler

Chief Executive Officer at IDORSIA LTD

53 year

Health Technology

Consumer Services

Profile

Roland Wandeler is President-Biopharma Business Unit at Grifols SA since 2024.
Former roles include Chief Executive Officer at Sundance Biosciences, Inc. from 2022 to 2023, VP, GM-US Bone Health & Cardiology Business Unit at Amgen, Inc., and Chief Operating Officer at MorphoSys AG from 2020 to 2021.
Education includes graduate and doctorate degrees from the Swiss Federal Institute of Technology.

Roland Wandeler active positions

Companies	Position	Start
GRIFOLS, S.A.	Corporate Officer/Principal	2023-12-31
IDORSIA LTD	Chief Executive Officer	2026-09-30

All active positions of Roland Wandeler

Former positions of Roland Wandeler

Companies	Position	End
Encinal Bio, Inc.	Chief Executive Officer	2023-09-30
MORPHOSYS AG	Chief Operating Officer	2021-12-30
AMGEN INC.	Corporate Officer/Principal	-

See the detail of Roland Wandeler's experience

Education of Roland Wandeler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roland Wandeler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Grifols SA Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies	Health Technology
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Idorsia Ltd. Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs	Health Technology
Encinal Bio, Inc.